Bennett Selby Investments’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.94M Buy
2,455
+39
+2% +$39.8K 0.94% 19
2026
Q1
$2.22M Buy
2,416
+6
+0.2% +$6.08K 0.78% 24
2025
Q4
$2.59M Buy
2,410
+66
+3% +$63.1K 0.83% 24
2025
Q3
$1.79M Buy
2,344
+722
+45% +$537K 0.59% 29
2025
Q2
$1.26M Buy
1,622
+660
+69% +$513K 0.45% 37
2025
Q1
$795K Buy
962
+362
+60% +$301K 0.31% 48
2024
Q4
$463K Buy
600
+57
+10% +$47.2K 0.18% 56
2024
Q3
$481K Buy
543
+31
+6% +$27.9K 0.2% 52
2024
Q2
$464K Buy
512
+25
+5% +$20K 0.21% 50
2024
Q1
$379K Buy
487
+103
+27% +$73.3K 0.18% 53
2023
Q4
$224K Buy
+384
New +$224K 0.11% 60

Other funds holding LLY

Bennett Selby Investments's LLY Position: Q2 2026 in Review

Bennett Selby Investments increased its Eli Lilly (LLY) stake by 1.6% in Q2 2026, buying an estimated $39.8K and bringing the position to 2,455 shares worth $2.94M. The position accounts for 0.94% of the portfolio, ranked #19.

Bennett Selby Investments first reported a position in LLY in Q4 2023 and has held it in 11 quarters since. 2,501 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Bennett Selby Investments held 2,455 shares of Eli Lilly worth $2.94M as of Q2 2026.
  • Bennett Selby Investments bought 39 Eli Lilly shares in Q2 2026, an estimated $39.8K.
  • Eli Lilly made up 0.94% of Bennett Selby Investments's portfolio in Q2 2026, its #19 holding.
  • Bennett Selby Investments first reported a position in Eli Lilly in Q4 2023 and has held it in 11 quarters since.
  • 2,501 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Bennett Selby Investments's 13F filing for Q2 2026, filed 24 Jul 2026.